Skip to main content

Closing Bell: Cipher Pharmaceuticals Inc down on Thursday (CPH)

Automated Summaries - The Globe and Mail - Thu Jul 25, 4:01PM CDT

Today during trading, Cipher Pharmaceuticals Inc stock opened at $8.84 and closed at $8.81. Intraday prices ranged from a low of $8.81 to a high of $8.99.

The price dipped -1.23% from the previous day's close of $8.92.

Today across North America, the TSX Composite closed -0.14% at 22608.03, the S&P 500 closed -2.31% at 5427.13, the Dow Jones Industrial Average closed -1.25% at 39853.87 and the Nasdaq Composite closed -3.64% at 17342.41.

Cipher Pharmaceuticals Inc traded under CPH on the Toronto Stock Exchange (TSX).

Trading volume was 13,070 on 61 total trades, with an average volume of 20,642 in the last five days.

Trading across the entire TSX saw 3,490 price advancers against 1,736 declines and 92 unchanged.

During the prior 52 weeks, CPH.TO has traded as high as $10.33 (May 10,2024) and low as $3.35 (August 08,2023). Moreover, in the last 52 weeks, Cipher Pharmaceuticals Inc's shares have risen 138.75%, while this year, they have surged 59.03%.

Following today's trading, Cipher Pharmaceuticals Inc has a market capitalization of $215.09 million on a float of 24,113 shares outstanding. Its annual EPS is $0.90.

Cipher Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Based on 2.00 analysts, Cipher Pharmaceuticals Inc gets an average recommendation of "Moderate Buy" according to Zacks. Currently, there are 1 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..